Hills-Derm-Complete

immagine

Attività svolta

Desidero ricevere una copia cartacea
Informativa sulla privacy
Iscrizione alla newsletter

Stato epilettico: gestione terapeutica

Bibliografia

1. Brandt C, Bethmann K, Gastens AM et coll. The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol. Dis. 2006;24(1):202-211.

2. Charalambous M, Volk HA, Tipold A et coll. Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: a multi-center randomized parallel group clinical study. J. Vet. Intern. Med. 2019;33(6):2709-2717.

3. Charalambous M, Bhatti SFM, Van Ham L et coll. Intranasal midazolam versus rectal diazepam for the management of canine status epilepticus: a multicenter randomized parallel-group clinical trial. J. Vet. Intern. Med. 2017;31(4):1149-1158.

4. Charalambous M, Volk HA, Van Ham L et coll. First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines. BMC Vet. Res. 2021;17(1):103.

5. Deeb TZ, Maguire J, Moss SJ. Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures. Epilepsia. 2012;53:79-88.

6. Eagleson JS, Platt SR, Strong DL et coll. Bioavailability of a novel midazolam gel after intranasal administration in dogs. Am. J. Vet. Res. 2012;73(4):539-545.

7. Fuhrer L. Conduite à tenir en neurologie du chien et du chat. Med’Com. 2021:320p.

8. Fuhrer L. Changements de traitements antiépileptiques et cas particulier du chat. Point Vét. 2017;(380).

9. Fuhrer L. L’épilepsie idiopathique: définition, classification et molécules. Point Vét. 2017;(380).

10. Fuhrer L. Recommandations actuelles pour le traitement de l’épilepsie idiopathique. Point Vét. 2017;(380).

11. Henry RJ, Ruano N, Casto D et coll. A pharmacokinetic study of midazolam in dogs: nasal drop versus atomizer administration. Pediatr. Dent. 1998;20(5):321-326.

12. Hoehne SN, Yozova ID, Vidondo B et coll. Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on electrolyte and acid-base variables in dogs with suspected intracranial hypertension. J. Vet. Intern. Med. 2021;35(1):341-351.

13. Laquay N, Prieur S, Greff B et coll. Le syndrome de perfusion du propofol. Ann. Fr. Anesth. Réanim. 2010;29(5):377-386.

14. Löscher W. Drug transporters in the epileptic brain. Epilepsia. 2007;48:8-13.

15. Lui CY, Amidon GL, Goldberg A. Intranasal absorption of flurazepam, midazolam, and triazolam in dogs. J. Pharm. Sci. 1991;80(12):1125-1129.

16. Magnin M, Barthélemy A. Conduite à tenir face à un traumatisme crânien chez le chien et le chat. Prat. Vét. 2016;51:76-79.

17. Mallard JM, Rieser TM, Peterson NW. Propofol infusion-like syndrome in a dog. Can. Vet. J. 2018;59(11):1216-1222.

18. Mealey KL, Boothe DM. Bioavailability of benzodiazepines following rectal administration of diazepam in dogs. J. Vet. Pharmacol. Ther. 1995;18(1):72-74.

19. Musulin SE, Mariani CL, Papich MG. Diazepam pharmacokinetics after nasal drop and atomized nasal administration in dogs. J. Vet. Pharmacol. Ther. 2011;34(1):17-24.

20. Naylor DE. Treating acute seizures with benzodiazepines: does seizure duration matter? Epileptic Disord. 2014;16:S69-S83.

21. Naylor DE, Liu H, Niquet J et coll. Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus. Neurobiol. Dis. 2013;54:225-238.

22. Niquet J, Baldwin R, Suchomelova L et coll. Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment. Ann. N. Y. Acad. Sci. 2016;1378(1):166-173.

23. Papich MG, Alcorn J. Absorption of diazepam after its rectal administration in dogs. Am. J. Vet. Res. 1995;56(12):1629-1636.

24. Patterson EN. Status epilepticus and cluster seizures. Vet. Clin. North Am. Small Anim. Pract. 2014;44(6):1103-1112.

25. Pedersoli WM, Wike JS, Ravis WR. Pharmacokinetics of single doses of phenobarbital given intravenously and orally to dogs. Am. J. Vet. Res. 1987;48(4):679-683.

26. Platt S, Garosi L. Appendices 1: Emergency drug use; 2: Units and reference ranges. In: Small Animimal Neurological Emergencies. CRC Press. 2012:610-621.

27. Platt S, Garosi L. Fluid therapy. In: Small Animal Neurological Emergencies. CRC Press. 2012:572-591.

28. Platt S, Garosi L. Respiratory and cardiovascular support. In: Small Animal Neurological Emergencies. CRC Press. 2012:36-61. 29. Platt S, Garosi L. Status epilepticus. In: Small Animal Neurological Emergencies. CRC Press. 2012:418-433.

30. Probst CW, Thomas WB, Moyers TD et coll. Evaluation of plasma diazepam and nordiazepam concentrations following administration of diazepam intravenously or via suppository per rectum in dogs. Am. J. Vet. Res. 2013;74(4):611-615.

31. Sear JW, Diedericks J, Foex P. Continuous infusions of propofol administered to dogs: effects on ICG and propofol disposition. Br. J. Anaesth. 1994;72(4):451-455.

32. Silayeva L, Deeb TZ, Hines RM et coll. KCC2 activity is critical in limiting the onset and severity of status epilepticus. Proc. Natl. Acad. Sci. USA. 2015;112(11):3523-3528.

33. Volk HA, Löscher W. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain. 2005;128:1358-1368.

34. Wasterlain CG, Naylor DE, Liu H et coll. Trafficking of NMDA receptors during status epilepticus: therapeutic implications. Epilepsia. 2013;54:78-80.

35. Yozova ID, Howard J, Henke D et coll. Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - A pilot study. BMC Vet. Res. 2017;13(1):185.

36. Zimmermann R, Hülsmeyer V, Sauter-Louis C et coll. Status epilepticus and epileptic seizures in dogs. J. Vet. Intern. Med. 2009;23(5):970-976.

TORNA INDIETRO
Abbonati per accedere

Dal web internazionale
06/06/2024

Patologia comparata del tumore alla prostata del cane e dell'uomo

Sebbene relativamente raro nei cani, il cancro alla prostata (PCa) è il tumore non cutaneo più comune negli uomini. Le ghiandole prostatiche umane e canine condividono molte caratteristiche funzionali, anatomiche e fisiologiche. A causa di queste somiglianze, il PCa canino è stato proposto come modello per il PCa negli uomini.

 
 
Formazione a distanza abbinata a SUMMA

SPC-sviluppo-professionale-continuo